What is the current Price Target for the Achieve Life Sciences, Inc. stock?

The average Achieve Life Sciences, Inc. target price is $15.56. This is 542.79% higher than the current stock price. The highest price target is 1,139.67%, the lowest is 313.22%. 9 Analysts have issued a price target Achieve Life Sciences, Inc. 2026 .

How high will the Achieve Life Sciences, Inc. stock rise?

No reliable answer can be given as to how high the Achieve Life Sciences, Inc. stock will rise. The performance of stocks, including the Achieve Life Sciences, Inc. stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Achieve Life Sciences, Inc. stock today?

The performance of Achieve Life Sciences, Inc. stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Achieve Life Sciences, Inc. stock fall?

The decline in Achieve Life Sciences, Inc. stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Achieve Life Sciences, Inc. Forecast, price target & analysts

$2.17

10.33% today

Nasdaq, Apr 04, 08:11 pm CET

ISIN

US0044682039

Symbol

ACHV

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Biotechnology

Overview Dividends Analysts Charts News Strategies

Achieve Life Sciences, Inc. Target price 2025 - Analyst rating & recommendation

Achieve Life Sciences, Inc. Classifications & Recommendation:

Buy

100%

Achieve Life Sciences, Inc. Price Target

Target Price	$15.56
Price	$2.42
Potential	542.79% register free of charge
Number of Estimates	9

	9 Analysts have issued a price target Achieve Life Sciences, Inc. 2026 . The average Achieve Life Sciences, Inc. target price is $15.56. This is 542.79% register free of charge higher than the current stock price. The highest price target is $30.00 1,139.67% register free of charge , the lowest is $10.00 313.22% register free of charge .
	A rating was issued by 8 analysts: 8 Analysts recommend Achieve Life Sciences, Inc. to buy, 0 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Achieve Life Sciences, Inc. stock has an average upside potential 2026 of 542.79% register free of charge . Most analysts recommend the Achieve Life Sciences, Inc. stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '24	2025 Estimates
Earnings Per Share $	-1.24	-1.17
	17.33%	5.65%
P/E		negative

5 Analysts have issued a Achieve Life Sciences, Inc. forecast for earnings per share. The average Achieve Life Sciences, Inc. EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$-1.24	17.33%
2025	$-1.17 5.65% Unlock
2026	$-0.75 35.90% Unlock
2027	$-0.23 69.33% Unlock
2028	$0.52 326.09% Unlock
2029	$2.41 363.46% Unlock

Current	-1.97	8.80%
2025	-2.06 4.57% Unlock
2026	-3.22 56.31% Unlock
2027	-10.63 230.12% Unlock
2028	4.65 143.74% Unlock
2029	1.01 78.28% Unlock

Achieve Life Sciences, Inc....

Current Achieve Life Sciences, Inc. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
Rodman & Renshaw	Locked ➜ Locked	Locked	Nov 14 2024
Raymond James	Locked ➜ Locked	Locked	Sep 27 2024

Analyst Rating	Date
Locked Rodman & Renshaw: Locked ➜ Locked	Nov 14 2024
Locked Raymond James: Locked ➜ Locked	Sep 27 2024

Discover more stocks with a high price target

Novo Nordisk 83.92%

Coinbase Global, Inc. 83.53%

BioNTech SE - ADR 50.09%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now